Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer

被引:28
作者
Chen, Feilong [1 ]
Xiao, Mei [2 ]
Hu, Shaofan [3 ]
Wang, Meng [3 ]
机构
[1] Chengdu Sport Univ, Inst Sports Med & Hlth, Expert Ctr Sichuan Prov, Sports Med Key Lab Sichuan Prov, Chengdu, Peoples R China
[2] Chongqing Univ, Coll Bioengn, Chongqing, Peoples R China
[3] Third Mil Med Univ, Mil Med Univ 3, Dept Biochem & Mol Biol, Chongqing, Peoples R China
基金
中国博士后科学基金;
关键词
Keap1; Nrf2; cancer; structure; function; transcriptional regulation; prevention; clinical; TRANSCRIPTION FACTOR NRF2; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; SIGNALING PATHWAY; ANTIOXIDANT RESPONSE; PROTEASOMAL DEGRADATION; MOLECULAR-MECHANISMS; STRUCTURAL BASIS; LUNG-CANCER; ACTIVATION;
D O I
10.3389/fonc.2024.1381467
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Keap1-Nrf2 signaling pathway is a major regulator of the cytoprotective response, participating in endogenous and exogenous stress caused by ROS (reactive oxygen species). Nrf2 is the core of this pathway. We summarized the literature on Keap1-Nrf2 signaling pathway and summarized the following three aspects: structure, function pathway, and cancer and clinical application status. This signaling pathway is similar to a double-edged sword: on the one hand, Nrf2 activity can protect cells from oxidative and electrophilic stress; on the other hand, increasing Nrf2 activity can enhance the survival and proliferation of cancer cells. Notably, oxidative stress is also considered a marker of cancer in humans. Keap1-Nrf2 signaling pathway, as a typical antioxidant stress pathway, is abnormal in a variety of human malignant tumor diseases (such as lung cancer, liver cancer, and thyroid cancer). In recent years, research on the Keap1-Nrf2 signaling pathway has become increasingly in-depth and detailed. Therefore, it is of great significance for cancer prevention and treatment to explore the molecular mechanism of the occurrence and development of this pathway.
引用
收藏
页数:12
相关论文
共 137 条
[81]   The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation [J].
Nioi, P ;
Nguyen, T ;
Sherratt, PJ ;
Pickett, CB .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (24) :10895-10906
[82]   Activation of the Nrf2/ARE pathway via S-alkylation of cysteine 151 in the chemopreventive agent-sensor Keap1 protein by falcarindiol, a conjugated diacetylene compound [J].
Ohnuma, Tomokazu ;
Nakayama, Shinji ;
Anan, Eisaburo ;
Nishiyama, Takahito ;
Ogura, Kenichiro ;
Hiratsuka, Akira .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2010, 244 (01) :27-36
[83]   An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma [J].
Ooi, Aikseng ;
Wong, Jing-Chii ;
Petillo, David ;
Roossien, Douglas ;
Perrier-Trudova, Victoria ;
Whitten, Douglas ;
Min, Bernice Wong Hui ;
Tan, Min-Han ;
Zhang, Zhongfa ;
Yang, Ximing J. ;
Zhou, Ming ;
Gardie, Betty ;
Molinie, Vincent ;
Richard, Stephane ;
Tan, Puay Hoon ;
Teh, Bin Tean ;
Furge, Kyle A. .
CANCER CELL, 2011, 20 (04) :511-523
[84]   Itaconate helps KEAP1's cool [J].
Otto, Grant .
NATURE REVIEWS IMMUNOLOGY, 2018, 18 (05) :294-294
[85]   Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer [J].
Padmanabhan, B ;
Tong, KI ;
Ohta, T ;
Nakamura, Y ;
Scharlock, M ;
Ohtsuji, M ;
Kang, MI ;
Kobayashi, A ;
Yokoyama, S ;
Yamamoto, M .
MOLECULAR CELL, 2006, 21 (05) :689-700
[86]   NRF2: KEAPing Tumors Protected [J].
Pillai, Ray ;
Hayashi, Makiko ;
Zavitsanou, Anastasia-Maria ;
Papagiannakopoulos, Thales .
CANCER DISCOVERY, 2022, 12 (03) :625-643
[87]   First Experience With Proteasome Inhibitor Treatment of Radioiodine Nonavid Thyroid Cancer Using Bortezomib [J].
Putzer, Daniel ;
Gabriel, Micheal ;
Kroiss, Alexander ;
Madleitner, Ruth ;
Eisterer, Wolfgang ;
Kendler, Dorota ;
Uprimny, Christian ;
Bale, Reto J. ;
Gastl, Guenther ;
Virgolini, Irene J. .
CLINICAL NUCLEAR MEDICINE, 2012, 37 (06) :539-544
[88]   Regulation of ferroptosis by noncoding RNAs: a novel promise treatment in esophageal squamous cell carcinoma [J].
Qiao, Guanen ;
Zhang, Wenjuan ;
Dong, Kui .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2022, 477 (09) :2193-2202
[89]   Oncogenic Activation of Nrf2, Though as a Master Antioxidant Transcription Factor, Liberated by Specific Knockout of the Full-Length Nrf1α that Acts as a Dominant Tumor Repressor [J].
Qiu, Lu ;
Wang, Meng ;
Hu, Shaofan ;
Ru, Xufang ;
Ren, Yonggang ;
Zhang, Zhengwen ;
Yu, Siwang ;
Zhang, Yiguo .
CANCERS, 2018, 10 (12)
[90]   Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism [J].
Ren, Dongmei ;
Villeneuve, Nicole F. ;
Jiang, Tao ;
Wu, Tongde ;
Lau, Alexandria ;
Toppin, Henry A. ;
Zhang, Donna D. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (04) :1433-1438